GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Petlife Pharmaceuticals PTLF · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

At a glance

Figures in USD, from our data supplier.

FY2017

Net income

−$23.3m

FY2014FY2017

Free cash flow

−$318,918

FY2014FY2017

Shareholders' equity

−$1.4m

FY2014FY2017

Income statement

Fiscal years

FY2017FY2016FY2015FY2014
Gross profit−$17,915—−$220,733−$60,079
Research and development———$73,198
Operating income−$22.7m−$3.7m−$1.9m−$1.5m
Net income−$23.3m−$3.7m−$1.9m−$1.5m
Diluted earnings per share-0.31-0.17-0.17-0.14

Balance sheet

At each fiscal year end

FY2017FY2016FY2015FY2014
Total assets$55,004$1,172$5,400$17,434
Cash and short-term investments$54,254$1,172—$6,852
Total liabilities$1.4m$3.2m$370,527—
Debt$717,176$153,011$10,000—
Shareholders' equity−$1.4m−$3.2m−$365,127$17,434
Shares outstanding74m22m11m11m

Cash flow

Fiscal years

FY2017FY2016FY2015FY2014
Cash from operations−$318,918−$151,839−$22,034−$267,066
Capital spending——−$600−$600
Free cash flow−$318,918−$151,839−$22,634−$267,666

Latest quarters

By quarter end

Feb 2018Nov 2017Aug 2017May 2017Feb 2017Nov 2016Aug 2016May 2016
Gross profit——−$17,915—————
Operating income−$182,670−$193,308−$1.7m−$571,980−$1.3m−$19.1m−$3.3m−$123,989
Net income−$427,064−$466,660−$2.0m−$815,017−$1.3m−$19.1m−$3.3m−$123,989
Diluted earnings per share-0.01-0.01-0.03-0.01-0.02-0.88-0.15-0.01
Total assets$7,856$57,641$55,004$270,321$213,378$28,996$1,172$5,400
Cash and short-term investments$7,856$54,312$54,254$321$445$28,996$1,172—
Debt$801,654$743,886$717,176$833,358$401,693$373,363$153,011$10,000
Shareholders' equity−$2.0m−$1.8m−$1.4m−$1.3m−$912,416−$4.1m−$3.2m−$648,824

Growth per year

Compound annual rate

3 years5 years10 years
Operating income146.5%54.4%57.2%
Net income148.7%58.6%57.4%

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return0%0%-53%26900%98%913%258416%1554%-34%47117%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 5-to-1 reverse split · 12 Sept 2016
  • 20-to-1 reverse split · 12 Aug 2014
  • 40-to-1 reverse split · 12 Jul 2012
  • 100-to-1 reverse split · 4 Oct 2010
  • 70-to-1 reverse split · 17 Sept 2009
  • 3-for-1 split · 11 Feb 2008

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.